Hosted on MSN5h
GLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett's
A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
Becker's ASC6h
GLP-1s and colonoscopy: 3 notes
The use of glucagon-like peptide-1 receptor agonists is likely to increase the risks of inadequate bowel preparation for colonoscopy, according to a study published Feb. 12 in The American Journal of ...
Medscape8h
HFpEF and Obesity: Breakthrough Results With GLP-1 Therapies
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Yes, GLP-1 Medications Really Do Reduce Alcohol Cravings, Per A New Study
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
BioSpace21h
Aardvark Therapeutics Gets $94 Million IPO to Power Obesity Treatments
Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...